Co-Authors
This is a "connection" page, showing publications co-authored by JEFFREY N MYERS and YOKO TAKAHASHI.
Connection Strength
1.056
-
Identification of markers predictive for response to induction chemotherapy in patients with sinonasal undifferentiated carcinoma. Oral Oncol. 2019 10; 97:56-61.
Score: 0.181
-
Identification of novel diagnostic markers for sinonasal undifferentiated carcinoma. Head Neck. 2019 08; 41(8):2688-2695.
Score: 0.176
-
Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity. Oral Oncol. 2018 12; 87:49-57.
Score: 0.171
-
Human epidermal growth factor receptor 2/neu as a novel therapeutic target in sinonasal undifferentiated carcinoma. Head Neck. 2016 04; 38 Suppl 1:E1926-34.
Score: 0.141
-
Comprehensive assessment of prognostic markers for sinonasal squamous cell carcinoma. Head Neck. 2014 Aug; 36(8):1094-102.
Score: 0.121
-
Establishment and characterization of novel cell lines from sinonasal undifferentiated carcinoma. Clin Cancer Res. 2012 Nov 15; 18(22):6178-87.
Score: 0.112
-
Vandetanib restores head and neck squamous cell carcinoma cells' sensitivity to cisplatin and radiation in vivo and in vitro. Clin Cancer Res. 2011 Apr 01; 17(7):1815-27.
Score: 0.100
-
Molecular profiling of sinonasal undifferentiated carcinoma. Head Neck. 2014 Jan; 36(1):15-21.
Score: 0.029
-
Theraputic targeting of Trk supresses tumor proliferation and enhances cisplatin activity in HNSCC. Cancer Biol Ther. 2010 Sep 15; 10(6):644-53.
Score: 0.024